Multiple studies, including our own, have determined that IGF2BP1 is specifically highly expressed in ETV-RUNX1 translocated B-ALL and lowly expressed in MLL-r B-ALL patient samples [143–145]. This evidence concerns the gene IGF2BP1 and acute lymphoblastic leukemia.